Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Marks

Showing results (561-570 of 683) with videos related to

Pageof 69
Sort By:
Haematologica|January 26, 2013
The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trialDavid I Marks, Anthony V Moorman, Lucy Chilton, et al.
Science Translational Medicine|November 17, 2017
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulationAntonio Galleu, Yanira Riffo-Vasquez, Cristina Trento, et al.
Bone Marrow Transplantation|August 24, 2004
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplantM Eapen, S A Giralt, M M Horowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2010
Second unrelated donor hematopoietic cell transplantation for primary graft failureJeffrey Schriber, Manza-A Agovi, Vincent Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2009
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphomaMarcel P Devetten, Parameswaran N Hari, Jeanette Carreras, et al.
Bone Marrow Transplantation|December 11, 2012
Effects of spleen status on early outcomes after hematopoietic cell transplantationG Akpek, M C Pasquini, B Logan, et al.
Blood Advances|September 3, 2021
IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trialRachel J Mitchell, Amy A Kirkwood, Emilio Barretta, et al.
Bone Marrow Transplantation|March 7, 1998
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemiaJ R Passweg, P Tiberghien, J Y Cahn, et al.
Blood|December 1, 2007
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)Anthony H Goldstone, Susan M Richards, Hillard M Lazarus, et al.
Blood|April 21, 2010
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remissionDavid I Marks, Tao Wang, Waleska S Pérez, et al.
Pageof 69

Showing results (561-570 of 683) with videos related to

Sort By:
Pageof 69
Haematologica|January 26, 2013
The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trialDavid I Marks, Anthony V Moorman, Lucy Chilton, et al.
Science Translational Medicine|November 17, 2017
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulationAntonio Galleu, Yanira Riffo-Vasquez, Cristina Trento, et al.
Bone Marrow Transplantation|August 24, 2004
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplantM Eapen, S A Giralt, M M Horowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2010
Second unrelated donor hematopoietic cell transplantation for primary graft failureJeffrey Schriber, Manza-A Agovi, Vincent Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2009
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphomaMarcel P Devetten, Parameswaran N Hari, Jeanette Carreras, et al.
Bone Marrow Transplantation|December 11, 2012
Effects of spleen status on early outcomes after hematopoietic cell transplantationG Akpek, M C Pasquini, B Logan, et al.
Blood Advances|September 3, 2021
IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trialRachel J Mitchell, Amy A Kirkwood, Emilio Barretta, et al.
Bone Marrow Transplantation|March 7, 1998
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemiaJ R Passweg, P Tiberghien, J Y Cahn, et al.
Blood|December 1, 2007
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)Anthony H Goldstone, Susan M Richards, Hillard M Lazarus, et al.
Blood|April 21, 2010
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remissionDavid I Marks, Tao Wang, Waleska S Pérez, et al.
Pageof 69